• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高效液相色谱法分析8-甲氧基补骨脂素。

Analysis of 8-methoxypsoralen by high-performance liquid chromatography.

作者信息

Ketchum C H, Robinson C A, Huang S T

机构信息

Department of Pathology, University of Alabama, Birmingham 35294.

出版信息

Clin Chem. 1990 Nov;36(11):1956-7.

PMID:2242576
Abstract

We report a simple and rapid procedure for assaying 8-methoxypsoralen (8-MOP) in plasma by high-performance liquid chromatography (HPLC). The standard curve for the assay is linear for 8-MOP from 15 to 500 micrograms/L (y = 0.002x-0.01, r = 0.99) with a lower limit of detection of 1.5 micrograms/L. Intra-assay precision (CV) was 6.0% at the 100 micrograms/L concentration and 10.0% at 50 micrograms/L (n = 30 each). Interassay precision was 6.4% at 100 micrograms/L and 7.0% at 50 micrograms/L (n = 50 each). Extraction recovery of 8-MOP was 98%. Common antiarrhythmics, sedatives, and hypnotics were found not to interfere.

摘要

我们报告了一种通过高效液相色谱法(HPLC)测定血浆中8-甲氧基补骨脂素(8-MOP)的简单快速方法。该测定的标准曲线在8-MOP浓度为15至500微克/升时呈线性(y = 0.002x - 0.01,r = 0.99),检测下限为1.5微克/升。在100微克/升浓度下,批内精密度(CV)为6.0%,在50微克/升时为10.0%(每组n = 30)。批间精密度在100微克/升时为6.4%,在50微克/升时为7.0%(每组n = 50)。8-MOP的提取回收率为98%。发现常见的抗心律失常药、镇静剂和催眠药不会产生干扰。

相似文献

1
Analysis of 8-methoxypsoralen by high-performance liquid chromatography.采用高效液相色谱法分析8-甲氧基补骨脂素。
Clin Chem. 1990 Nov;36(11):1956-7.
2
Simple equilibrium dialysis-high-performance liquid chromatographic method for the in vitro assessment of 5-methoxypsoralen bound to human albumin.用于体外评估与人类白蛋白结合的5-甲氧基补骨脂素的简单平衡透析-高效液相色谱法。
J Chromatogr. 1991 Feb 22;539(2):443-8. doi: 10.1016/s0021-9673(01)83953-4.
3
[Determination of 8-methoxypsoralen in mouse plasma by high performance liquid chromatography and its application to pharmacokinetic study].
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Oct 18;50(5):792-796.
4
Spectrofluorimetric determination of 5-methoxypsoralen pharmacokinetic in patients' serum.荧光分光光度法测定患者血清中5-甲氧基补骨脂素的药代动力学。
Exp Dermatol. 1997 Apr;6(2):57-63. doi: 10.1111/j.1600-0625.1997.tb00147.x.
5
Skin concentration of 8-methoxypsoralen, 5-methoxypsoralen and 4,5,8-trimethylpsoralen in guinea pigs.豚鼠皮肤中8-甲氧基补骨脂素、5-甲氧基补骨脂素和4,5,8-三甲基补骨脂素的浓度。
J Dermatol Sci. 1993 Feb;5(1):19-24. doi: 10.1016/0923-1811(93)90101-t.
6
Simple and rapid determination of psoralens in topic solutions using liquid chromatography.使用液相色谱法简单快速地测定局部用溶液中的补骨脂素。
J Pharm Biomed Anal. 2002 Jan 1;27(1-2):217-24. doi: 10.1016/s0731-7085(01)00537-4.
7
8-methoxypsoralen reduces AKT phosphorylation, induces intrinsic and extrinsic apoptotic pathways, and suppresses cell growth of SK-N-AS neuroblastoma and SW620 metastatic colon cancer cells.8-甲氧基补骨脂素降低 AKT 磷酸化,诱导内在和外在凋亡途径,并抑制 SK-N-AS 神经母细胞瘤和 SW620 转移性结肠癌细胞的生长。
J Ethnopharmacol. 2017 Jul 31;207:19-29. doi: 10.1016/j.jep.2017.06.010. Epub 2017 Jun 13.
8
Evidence for uptake of 8-methoxypsoralen and 5-methoxypsoralen by cellular nuclei.细胞核摄取8-甲氧基补骨脂素和5-甲氧基补骨脂素的证据。
Mutat Res. 1988 Jan;197(1):51-8. doi: 10.1016/0027-5107(88)90139-x.
9
Chronopharmacokinetics of 5-methoxypsoralen.5-甲氧基补骨脂素的时辰药代动力学
Acta Derm Venereol. 1990;70(6):515-7.
10
Evaluation and routine application of the novel restricted-access precolumn packing material Alkyl-Diol Silica: coupled-column high-performance liquid chromatographic analysis of the photoreactive drug 8-methoxypsoralen in plasma.新型限进性预柱填充材料烷基二醇硅胶的评价与常规应用:血浆中光反应性药物8-甲氧基补骨脂素的偶合柱高效液相色谱分析
J Chromatogr B Biomed Appl. 1995 Apr 21;666(2):315-22. doi: 10.1016/0378-4347(94)00578-s.

引用本文的文献

1
Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique).通过电穿孔进行环丙沙星和8-甲氧基补骨脂素的经皮采样(ETS技术)。
Int J Pharm. 2009 Mar 18;369(1-2):24-9. doi: 10.1016/j.ijpharm.2008.10.017. Epub 2008 Nov 5.